|
|
Volumn 26, Issue 20, 2008, Pages 3468-
|
|
Methylenetetrahydrofolate reductase gene polymorphisms: Genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);
FLUOROPYRIMIDINE;
FLUOROURACIL;
ANTINEOPLASTIC AGENT;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
TUMOR MARKER;
CANCER RESEARCH;
CANCER SURVIVAL;
COLON CANCER;
DNA POLYMORPHISM;
GENETIC ANALYSIS;
GENOMICS;
GENOTYPE;
HOMOZYGOSITY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
AGED;
COHORT ANALYSIS;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
NOTE;
PREDICTION AND FORECASTING;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COHORT STUDIES;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);
MIDDLE AGED;
POLYMORPHISM, GENETIC;
PREDICTIVE VALUE OF TESTS;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 49149086424
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.17.6479 Document Type: Letter |
|
Times cited : (10)
|
|
References (3)
|
